The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study

Background and aimsCardiac enzymes are recognized as a valuable tool for predicting the prognosis of various cardiovascular diseases. The prognostic value of alpha-hydroxybutyrate dehydrogenase (α-HBDH) in patients with intracerebral hemorrhage (ICH) was ambiguous and not evaluated.MethodsTwo hundre...

Full description

Bibliographic Details
Main Authors: Zhang Limin, Rasha Alsamani, Wu Jianwei, Shi Yijun, Wang Dan, Sun Yuehong, Liu Ziwei, Xu Huiwen, Wang Dongzhi, Zhao Xingquan, Zhang Guojun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.906249/full
_version_ 1811182083455844352
author Zhang Limin
Zhang Limin
Zhang Limin
Rasha Alsamani
Rasha Alsamani
Rasha Alsamani
Wu Jianwei
Shi Yijun
Shi Yijun
Shi Yijun
Wang Dan
Wang Dan
Wang Dan
Sun Yuehong
Sun Yuehong
Sun Yuehong
Liu Ziwei
Liu Ziwei
Liu Ziwei
Xu Huiwen
Xu Huiwen
Xu Huiwen
Wang Dongzhi
Wang Dongzhi
Wang Dongzhi
Zhao Xingquan
Zhang Guojun
Zhang Guojun
Zhang Guojun
author_facet Zhang Limin
Zhang Limin
Zhang Limin
Rasha Alsamani
Rasha Alsamani
Rasha Alsamani
Wu Jianwei
Shi Yijun
Shi Yijun
Shi Yijun
Wang Dan
Wang Dan
Wang Dan
Sun Yuehong
Sun Yuehong
Sun Yuehong
Liu Ziwei
Liu Ziwei
Liu Ziwei
Xu Huiwen
Xu Huiwen
Xu Huiwen
Wang Dongzhi
Wang Dongzhi
Wang Dongzhi
Zhao Xingquan
Zhang Guojun
Zhang Guojun
Zhang Guojun
author_sort Zhang Limin
collection DOAJ
description Background and aimsCardiac enzymes are recognized as a valuable tool for predicting the prognosis of various cardiovascular diseases. The prognostic value of alpha-hydroxybutyrate dehydrogenase (α-HBDH) in patients with intracerebral hemorrhage (ICH) was ambiguous and not evaluated.MethodsTwo hundred and thirteen Chinese patients with ICH participated in the study from December 2018 to December 2019. Laboratory routine tests and cardiac enzymes, including α-HBDH level, were examined and analyzed. All the patients were classified into two groups by the median value of α-HBDH: B1 <175.90 and B2 ≥175.90 U/L. The clinical outcomes included functional outcome (according to modified Rankin Scale (mRS) score ≥3), all-cause death, and recurrent cerebro-cardiovascular events 1 year after discharge. Associations between the α-HBDH and the outcomes were evaluated using logistic regression analysis. Univariate survival analysis was performed by the Kaplan–Meier method and log-rank test.ResultsOf the 213 patients, 117 had α-HBDH ≥175.90 U/L. Eighty-two patients had poor functional outcomes (mRS≥3). During the 1-year follow-up, a total of 20 patients died, and 15 of them had α-HBDH ≥175.90 U/L during the follow-up time. Moreover, 24 recurrent events were recorded. After adjusting confounding factors, α-HBDH (≥175.90) remained an indicator of poor outcome (mRS 3-6), all-cause death, and recurrent cerebro-cardiovascular events. The ORs for B2 vs. B1 were 4.78 (95% CI: 2.60 to 8.78, P = 0.001), 2.63 (95% CI: 0.80 to 8.59, P = 0.11), and 2.40 (95% CI: 0.82 to 7.02, P = 0.11) for poor functional outcomes with mRS ≥ 3, all-cause death, and recurrent cerebro-cardiovascular events, respectively.ConclusionIncreased α-HBDH at admission was independently related to poor functional outcome and all-cause mortality in patients with ICH at 1-year follow-up.
first_indexed 2024-04-11T09:27:15Z
format Article
id doaj.art-b9c5d677d49047b399b3a1cd1d3d5641
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-11T09:27:15Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-b9c5d677d49047b399b3a1cd1d3d56412022-12-22T04:32:00ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-10-011310.3389/fneur.2022.906249906249The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective studyZhang Limin0Zhang Limin1Zhang Limin2Rasha Alsamani3Rasha Alsamani4Rasha Alsamani5Wu Jianwei6Shi Yijun7Shi Yijun8Shi Yijun9Wang Dan10Wang Dan11Wang Dan12Sun Yuehong13Sun Yuehong14Sun Yuehong15Liu Ziwei16Liu Ziwei17Liu Ziwei18Xu Huiwen19Xu Huiwen20Xu Huiwen21Wang Dongzhi22Wang Dongzhi23Wang Dongzhi24Zhao Xingquan25Zhang Guojun26Zhang Guojun27Zhang Guojun28Department of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, ChinaBeijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, ChinaBackground and aimsCardiac enzymes are recognized as a valuable tool for predicting the prognosis of various cardiovascular diseases. The prognostic value of alpha-hydroxybutyrate dehydrogenase (α-HBDH) in patients with intracerebral hemorrhage (ICH) was ambiguous and not evaluated.MethodsTwo hundred and thirteen Chinese patients with ICH participated in the study from December 2018 to December 2019. Laboratory routine tests and cardiac enzymes, including α-HBDH level, were examined and analyzed. All the patients were classified into two groups by the median value of α-HBDH: B1 <175.90 and B2 ≥175.90 U/L. The clinical outcomes included functional outcome (according to modified Rankin Scale (mRS) score ≥3), all-cause death, and recurrent cerebro-cardiovascular events 1 year after discharge. Associations between the α-HBDH and the outcomes were evaluated using logistic regression analysis. Univariate survival analysis was performed by the Kaplan–Meier method and log-rank test.ResultsOf the 213 patients, 117 had α-HBDH ≥175.90 U/L. Eighty-two patients had poor functional outcomes (mRS≥3). During the 1-year follow-up, a total of 20 patients died, and 15 of them had α-HBDH ≥175.90 U/L during the follow-up time. Moreover, 24 recurrent events were recorded. After adjusting confounding factors, α-HBDH (≥175.90) remained an indicator of poor outcome (mRS 3-6), all-cause death, and recurrent cerebro-cardiovascular events. The ORs for B2 vs. B1 were 4.78 (95% CI: 2.60 to 8.78, P = 0.001), 2.63 (95% CI: 0.80 to 8.59, P = 0.11), and 2.40 (95% CI: 0.82 to 7.02, P = 0.11) for poor functional outcomes with mRS ≥ 3, all-cause death, and recurrent cerebro-cardiovascular events, respectively.ConclusionIncreased α-HBDH at admission was independently related to poor functional outcome and all-cause mortality in patients with ICH at 1-year follow-up.https://www.frontiersin.org/articles/10.3389/fneur.2022.906249/fullintracerebral hemorrhageoutcomesmortalityα-HBDHcardiovascular events
spellingShingle Zhang Limin
Zhang Limin
Zhang Limin
Rasha Alsamani
Rasha Alsamani
Rasha Alsamani
Wu Jianwei
Shi Yijun
Shi Yijun
Shi Yijun
Wang Dan
Wang Dan
Wang Dan
Sun Yuehong
Sun Yuehong
Sun Yuehong
Liu Ziwei
Liu Ziwei
Liu Ziwei
Xu Huiwen
Xu Huiwen
Xu Huiwen
Wang Dongzhi
Wang Dongzhi
Wang Dongzhi
Zhao Xingquan
Zhang Guojun
Zhang Guojun
Zhang Guojun
The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
Frontiers in Neurology
intracerebral hemorrhage
outcomes
mortality
α-HBDH
cardiovascular events
title The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
title_full The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
title_fullStr The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
title_full_unstemmed The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
title_short The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study
title_sort relationship of α hydroxybutyrate dehydrogenase with 1 year outcomes in patients with intracerebral hemorrhage a retrospective study
topic intracerebral hemorrhage
outcomes
mortality
α-HBDH
cardiovascular events
url https://www.frontiersin.org/articles/10.3389/fneur.2022.906249/full
work_keys_str_mv AT zhanglimin therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhanglimin therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhanglimin therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wujianwei therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhaoxingquan therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun therelationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhanglimin relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhanglimin relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhanglimin relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT rashaalsamani relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wujianwei relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT shiyijun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdan relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT sunyuehong relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT liuziwei relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT xuhuiwen relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT wangdongzhi relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhaoxingquan relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy
AT zhangguojun relationshipofahydroxybutyratedehydrogenasewith1yearoutcomesinpatientswithintracerebralhemorrhagearetrospectivestudy